| Trans-Middle-Ear Mucosal Gas Exchange Project 1, Specific Aim 1 (NCT01925482) | Cuneyt M. Alper | 2014-05-13 |
| 5HT2CR Balance in Brain Connectivity in Cocaine Dependence (NCT03921151) | Virginia Commonwealth University | 2014-05-13 |
| First Evaluation of Morphine Hydrochloride by Nebulisation in Healthy Volunteers (NCT01975753) | University Hospital, Rouen | 2014-05-13 |
| QUILT-3.018: Neukoplast™ (NK-92) for the Treatment of Refractory or Relapsed Acute Myeloid Leukemia (NCT00900809) | ImmunityBio, Inc. | 2014-05-12 |
| Single and Multiple Dosing Study in Hemodialysis Patients With Hyperphosphatemia in Japan (NCT02510274) | Astellas Pharma Inc | 2014-05-12 |
| Pharmacokinetic Food-effect Study of Abiraterone Acetate (AA) in Castration Resistant Prostate Cancer (NCT02730975) | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 2014-05-12 |
| A Multiple Dose Titration Study of MK-8892 in Participants With Pulmonary Hypertension and Left Heart Disease (MK-8892-007) (NCT02078557) | Merck Sharp & Dohme LLC | 2014-05-09 |
| Phase I Dose Escalation of Oral BAY1161909 in Combination With Intravenous Paclitaxel (NCT02138812) | Bayer | 2014-05-09 |
| Galectin Inhibitor (GR-MD-02) and Ipilimumab in Patients With Metastatic Melanoma (NCT02117362) | Providence Health & Services | 2014-05-08 |
| Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast Cancer (NCT01992952) | Velindre NHS Trust | 2014-05-07 |
| Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells (NCT02213705) | Assistance Publique - Hôpitaux de Paris | 2014-05-06 |
| A Phase Ib Dose De-escalation Study With BYL719 in Premenopausal Patients With Locally Advanced or Metastatic Breast Cancer (NCT02058381) | Novartis Pharmaceuticals | 2014-05-06 |
| A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumab (NCT02013154) | Leap Therapeutics, Inc. | 2014-05-05 |
| A Study to Evaluate a Skeletal-muscle Microbiopsy Technique With Dynamic Proteomic Measurement in Healthy Male Volunteers (NCT01962454) | GlaxoSmithKline | 2014-05-05 |
| Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1 (NCT02122952) | Novartis Gene Therapies | 2014-05-05 |
| Evaluating the Safety and Efficacy of Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load (NCT01933594) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-05-05 |
| A Study to Evaluate Safety, Tolerability, PK and PD of HLX01 in Patients With CD20-positive B-cell Lymphomas (NCT03218072) | Shanghai Henlius Biotech | 2014-05-04 |
| A Study to Test the Safety of the Investigational Drug Larotrectinib in Adults That May Treat Cancer (NCT02122913) | Bayer | 2014-05-04 |
| GRC 27864 First in Man, Single Ascending Dose Study in Healthy Volunteers (NCT02179645) | Glenmark Pharmaceuticals Ltd. India | 2014-05-01 |
| Bioequivalence of a FDC Tablet of Linagliptin/Metformin (2.5mg/750mg) Extended Release in Healthy Subjects (NCT02121509) | Boehringer Ingelheim | 2014-05-01 |
| Safety Study of TPI-287 to Treat CBS and PSP (NCT02133846) | University of California, San Francisco | 2014-05-01 |
| A Study of the Safety, Tolerability and Pharmacokinetics of HMPL-523 (NCT02105129) | Hutchison Medipharma Limited | 2014-05-01 |
| An Open-Label, Single-Dose Study to Determine the Metabolism and Elimination of 14C-Perampanel in Healthy Male Subjects (NCT02116907) | Eisai Inc. | 2014-05-01 |
| A Study of Cephalexin Suspension in Healthy Participants (NCT02123459) | Eli Lilly and Company | 2014-05-01 |
| A Study of Evacetrapib in Participants With Abnormal Cholesterol (NCT02168803) | Eli Lilly and Company | 2014-05-01 |
| Immunotherapy in Subjects With HPV-6 Associated Aerodigestive Precancerous Lesions and Malignancies (NCT02241369) | Inovio Pharmaceuticals | 2014-05-01 |
| Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB5 in Healthy Subjects (NCT02144714) | Samsung Bioepis Co., Ltd. | 2014-05-01 |
| Safety, Tolerability and Activity of SRX246 in Adults With Intermittent Explosive Disorder (NCT02055638) | Azevan Pharmaceuticals | 2014-05-01 |
| Novel Drug Delivery Technique Via Retroject Device (NCT02051946) | Molly Walsh | 2014-05-01 |
| Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators (NCT02145091) | Johns Hopkins University | 2014-05-01 |
| Ibrutinib and Lenalidomide With Dose Adjusted EPOCH-R in Subjects With Relapsed/Refractory Diffuse Large B-cell Lymphoma (NCT02142049) | Pharmacyclics LLC. | 2014-05-01 |
| A Trial to Evaluate the Safety and Tolerability of a Novel Medical Food for Management of Iron Deficiency Anemia (NCT03038633) | Milton S. Hershey Medical Center | 2014-05-01 |
| A Study To Understand How Radiolabelled PF-04449913 Is Taken Up By The Body, Broken Down And Then Removed From The Body (NCT02110342) | Pfizer | 2014-05-01 |
| Oral AGY for Celiac Disease (NCT01765647) | Igy Inc. | 2014-05-01 |
| A Study to Examine the Distribution of PF-06372865 in the Brain of Healthy Volunteers Using Positron Emission Tomography and a Radioactive Tracer Following Oral Administration of One Dose of PF-06372865 (NCT02138500) | Pfizer | 2014-05-01 |
| BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500 Post-Meal Glucose Control in Patients With Severe Insulin Resistance (NCT02324309) | Biodel | 2014-05-01 |
| Drug Interaction Study Between Bosutinib And Dabigatran (NCT02102633) | Pfizer | 2014-05-01 |
| Meditation for Emotional Numbing in Post-Traumatic Stress Disorder (NCT02163941) | Emory University | 2014-05-01 |
| Comparison of Postprandial Glucose Control Associated With BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500 (NCT02212951) | Biodel | 2014-05-01 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of Multiple Ascending Doses of ASP7962 in Healthy Subjects (NCT02136316) | Astellas Pharma Europe B.V. | 2014-05-01 |
| FAAH Inhibitor Trial for Adults With Tourette Syndrome (NCT02134080) | Yale University | 2014-05-01 |
| Parkinsonian Brain Repair Using Human Stem Cells (NCT02780895) | Celavie Bioscences, LLC | 2014-05-01 |
| Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme (NCT02078648) | Stemline Therapeutics, Inc. | 2014-05-01 |
| Evaluating the Safety and Immune Response to a Live H7N9 Influenza Virus Vaccine Followed by an Inactivated H7N9 Influenza Virus Vaccine, Given at Varying Intervals (NCT02151344) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-05-01 |
| A Phase I/IIa Study of GC3110A (Quadrivalent Influenza Vaccine) (NCT02121782) | Green Cross Corporation | 2014-05-01 |
| Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma (NCT02176720) | The Methodist Hospital Research Institute | 2014-05-01 |
| Phase I, Double-Blind,Placebo, MAD Study to Evaluate the Safety, Tolerability, PK, and PD of AMG 333 in Healthy Subjects and Migraine Subjects (NCT02132429) | Amgen | 2014-05-01 |
| A Randomised Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes (NCT02131246) | Novo Nordisk A/S | 2014-05-01 |
| Relative Bioavailability of Multiple Oral Doses of BI 187004 and Metformin After Co-administration Compared to Multiple Oral Doses of BI 187004 Alone and Metformin Alone in Healthy Male Subjects (NCT02109679) | Boehringer Ingelheim | 2014-05-01 |
| Relative Bioavailability and Food Effect Study of IX-01 Capsules in Healthy Men (NCT02139826) | Ixchelsis Limited | 2014-05-01 |
| Vitamin C and Liraglutide Effects on Hypoglycemia-induced Oxidative Stress, Inflammation and Endothelial Dysfunction in Type 1 Diabetes. (NCT02109315) | Anna Cruceta | 2014-05-01 |
| Bihemispheric Modulation of the Motor Cortex by Transcranial Direct Current Stimulation in Subacute Stroke Patients (NCT02158312) | Taipei Veterans General Hospital, Taiwan | 2014-05-01 |
| A Phase 1 Study Comparing AVP-786 With AVP-923 (NCT02336347) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2014-05-01 |
| Pharmacokinetics of Sufentanil Sublingual Microtablet 30 mcg and 15 mcg in Healthy Subjects (NCT02082236) | Talphera, Inc | 2014-05-01 |
| Study to Evaluate the Effect of Solifenacin and Mirabegron on the Tamsulosin Hydrochloride (HCl) Concentrations in Blood in Healthy Male Subjects (NCT02169713) | Astellas Pharma Europe B.V. | 2014-05-01 |
| Three Dosing Schedules of Oral Rigosertib in MDS Patients (NCT02075034) | Traws Pharma, Inc. | 2014-05-01 |
| Stereotactic Body Radiation Therapy and T-Cell Infusion in Treating Patients With Metastatic Kidney Cancer (NCT01943188) | Stanford University | 2014-05-01 |
| Single Ascending Dose Study of TRN-157 in Healthy Subjects (NCT02133339) | Theron Pharmaceuticals, Inc. | 2014-05-01 |
| Safety, Pharmacokinetics and Acceptability of PC-1005 for Vaginal Use (NCT02033109) | Population Council | 2014-05-01 |
| A Study of 2 Different Formulations of Insulin Lispro in Healthy Participants (NCT02111083) | Eli Lilly and Company | 2014-05-01 |
| Safety Study Of Chemotherapy Combined With Dendritic Cell Vaccine to Treat Breast Cancer (NCT02018458) | Baylor Research Institute | 2014-05-01 |
| Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Peritoneal Dialysis (NCT02143271) | Kyowa Kirin Co., Ltd. | 2014-05-01 |
| Pharmacokinetics and Drug Interaction Study Between Amlodipine,Olmesartan and Rosuvastatin in Healthy Adult Volunteers (NCT02089399) | Daewoong Pharmaceutical Co. LTD. | 2014-05-01 |
| Phase I Trial to Investigate Cafusertib Hydrochloride in Combination With Low Dose Cytarabine in Chinese Patients With Acute Myeloid Leukaemia (AML) (NCT02140606) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2014-05-01 |
| OmegaChild - Omega-3 Supplementation to Children Previously Treated for Cancer (NCT02134600) | Per Kogner | 2014-05-01 |
| Chloroquine as an Anti-autophagic Radiosensitizing Drug in Stage I-III Small Cell Lung Cancer (NCT01575782) | Maastricht Radiation Oncology | 2014-05-01 |
| Clinical Pharmacology of FYU-981 (Elder Subjects) (NCT02344875) | Fuji Yakuhin Co., Ltd. | 2014-05-01 |
| Phase I Open Label Dose Escalation Study to Investigate the Safety & Pharmacokinetics of AZD5312 in Patients With Androgen Receptor Tumors (NCT02144051) | AstraZeneca | 2014-05-01 |
| LDFWART With Docetaxel in Patients With Platinum-Resistant Recurrent Ovarian Carcinoma (NCT02083536) | University of Miami | 2014-05-01 |
| Phase 1 of EC1169 In Patients With Recurrent MCRPC (NCT02202447) | Endocyte | 2014-05-01 |
| A Dose Proportionality and Bioavailability Assessment of Buprenorphine Transdermal Delivery System Second Generation Patches (NCT02160067) | Mundipharma Research Limited | 2014-05-01 |
| A Drug Interaction Study Between Bosutinib And Aprepitant In Healthy Volunteers (NCT02058277) | Pfizer | 2014-05-01 |
| Inositol Hexaphosphate: A Novel Treatment Strategy for Bipolar Disorder? (NCT02081287) | San Diego Veterans Healthcare System | 2014-05-01 |
| Afatinib in Subjects With Kidney Dysfunction (NCT02096718) | Boehringer Ingelheim | 2014-05-01 |
| A Study To Estimate How Much Tafamidis Created In Different Ways Can Be Measured in Blood Samples (NCT02189330) | Pfizer | 2014-05-01 |
| Phase I Clinical Trial of Tremelimumab Plus MEDI3617 in Patients With Unresectable Stage III or Stage IV Melanoma (NCT02141542) | F. Stephen Hodi, MD | 2014-05-01 |
| A Phase I, Open-Label, Single-Center Study to Assess the Absorption, Metabolism, and Excretion of [14C]-AZD3293 (NCT02126514) | AstraZeneca | 2014-05-01 |
| TD-6450 MAD Study in HCV Infected Subjects (NCT02116543) | Theravance Biopharma | 2014-05-01 |
| Intraoperative Imagery of Breast Cancer With Folate-FITC (EC17) (NCT01994369) | University of Pennsylvania | 2014-05-01 |
| Effect of a High-fat Meal on the Pharmacokinetics of SHR3824 and Mass Balance Study in Healthy Subjects (NCT02353975) | Jiangsu HengRui Medicine Co., Ltd. | 2014-05-01 |
| MSB11022 in Healthy Subjects (NCT03014947) | Fresenius Kabi SwissBioSim GmbH | 2014-05-01 |
| Pharmacodynamics and Safety of CDFR0209 (NCT02710994) | Ajou University School of Medicine | 2014-05-01 |
| Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg/Hydrochlorothiazide 12.5 mg (T80/A5/H12.5 mg) Fixed-dose Combination (FDC) Tablet and T80/H12.5 mg Tab and A5 mg (Encap A2.5 mg Tab x2) Concomitant Use (NCT02129192) | Boehringer Ingelheim | 2014-05-01 |
| To Evaluate the Effect of AZD1722 on the Pharmacokinetics of Oral Midazolam in Healthy Volunteers (NCT02140268) | Ardelyx | 2014-05-01 |
| Phase I/II Feasibility Study Combining Brentuximab Vedotin With Second Line Salvage Chemotherapy (DHAP) in Hodgkin Lymphoma Patients (NCT02280993) | Marjolein Spiering | 2014-05-01 |
| Multiple Ascending Dose Study of DS-1093 in Healthy Subjects (NCT02142400) | Daiichi Sankyo | 2014-05-01 |
| Efficacy of Topical Calcipotriol-assisted AFL-PDT in Actinic Keratosis (NCT02976727) | Dong-A University | 2014-05-01 |
| Lexaptepid Pegol (NOX-H94) in ESA-hyporesponsive Anemia in Dialysis Patients (NCT02079896) | TME Pharma AG | 2014-05-01 |
| Safety Study of EF-022 ( Modified Vitamin D Binding Protein Macrophage Activator) in Subjects With Advanced Solid Tumors (NCT02052492) | Efranat Ltd. | 2014-05-01 |
| Fed Bioequivalence Study of CBZ Formulations (NCT02132897) | Center for Clinical Pharmacology Research Bdbeq S.A. | 2014-05-01 |
| Safety and Tolerability of XmAb®7195 in Adult Healthy Volunteers and Adult Subjects With a History of Allergic Rhinitis and/or Allergic Conjunctivitis and/or Atopic Dermatitis (NCT02148744) | Xencor, Inc. | 2014-05-01 |
| Triple vs. Dual Therapy (NCT02080858) | Medical University of Vienna | 2014-05-01 |
| A Phase 1 Study of the Clinical and Immunologic Effects of ALT-803 in Patients With Advanced Solid Tumors (NCT01946789) | Altor BioScience | 2014-05-01 |
| Effects of Anesthesia on Pediatric Surgical Patients With a History of Concussion - Phase I (NCT02118220) | Boston Children's Hospital | 2014-05-01 |
| A Safety, Tolerability, and Pharmacokinetics (PK) Study of AGN-223575 in Healthy Subjects (NCT02155543) | Allergan | 2014-05-01 |
| Phase I/II Trial of a Long Peptide Vaccine (LPV7) Plus TLR Agonists (NCT02126579) | Craig L Slingluff, Jr | 2014-05-01 |
| Phase I-II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation and Pharmacokinetics of PD-0332991 in Patients Suffering Metastatic Melanoma (NCT02202200) | Assistance Publique - Hôpitaux de Paris | 2014-05-01 |
| Phase 1 Trial of Chlorogenic Acid in Patients With Advanced Cancer (NCT02136342) | Chinese Academy of Medical Sciences | 2014-05-01 |
| Drug-drug Interaction Study (Telmisartan, Amlodipine, Chlorthalidone) (NCT02152969) | Yuhan Corporation | 2014-05-01 |
| ADAM17 Inhibitor/ Rituximab After Auto HCT for DLBCL (NCT02141451) | Masonic Cancer Center, University of Minnesota | 2014-05-01 |